Medical Oddities: Dogs share our mortality markers
-
By
-
Teraya Smith
-
September 2, 2026
-
5 min
By
Teraya Smith
September 2, 2026
Phase 3 findings showed longer median progression-free survival with zanidatamab-containing regimens vs trastuzumab plus chemotherapy.
August 25, 2026
Multi-ancestry polygenic models identify high-risk patients traditional screening may miss.
May 13, 2026
Chemsex at the pharmacy counter. Gut bacteria tracking helmet impacts. PMD predicting psychiatric illness bidirectionally. This week's research keeps landing in the same uncomfortable place: medicine is improvising.
by Kerri Miller
May 11, 2026